PCR-heteroduplex analysis of TCR γ, δ and TAL-1 deletions in T-acute lymphoblastic leukemias: Implications in the detection of minimal residual disease

Leukemia Research

Volumn 26, Issue 4, 2002, Pages 335-343

  Nirmala, K ^a   Rajalekshmy, K R ^a   Raman, S G ^a   Shanta, V ^a   Rajkumar, T ^a  

^a CANCER INSTITUTE WIA   (India)

Author keywords

HD; MRD; PCR; T cell ALL; TAL 1 deletion; TCR and gene rearrangements

Indexed keywords

PROTEIN; PROTEIN TAL 1; T LYMPHOCYTE RECEPTOR DELTA CHAIN; T LYMPHOCYTE RECEPTOR GAMMA CHAIN; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BONE MARROW; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; FEMALE; GENE DELETION; HETERODUPLEX ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MINIMAL RESIDUAL DISEASE; MOLECULAR CLONING; MORPHOLOGY; PATIENT MONITORING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RELAPSE; REMISSION;

ADOLESCENT; ADULT; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CHILD; CHILD, PRESCHOOL; DNA, NEOPLASM; DNA-BINDING PROTEINS; FEMALE; GENE DELETION; GENE REARRANGEMENT, DELTA-CHAIN T-CELL ANTIGEN RECEPTOR; GENE REARRANGEMENT, GAMMA-CHAIN T-CELL ANTIGEN RECEPTOR; HUMANS; LEUKEMIA, T-CELL, ACUTE; MALE; NEOPLASM, RESIDUAL; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; PROTO-ONCOGENE PROTEINS; RECURRENCE; TRANSCRIPTION FACTORS;

EID: 0036165015     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(01)00130-8     Document Type: Article

References (46)

1. Immunophenotype analysis of T-acute lymphoblastic leukemia in Madras, India
2. Detection of minimal residual disease in acute lymphoblastic leukemia by immunological marker analysis and PCR
3. Immunobiology of leukemia
4. The clinical significance of detection of residual disease in childhood ALL
5. Structural characterization of SIL, a gene frequently disrupted in T cell ALL
6. TAL-1 deletions in T-ALL as target for detection of MRD by PCR techniques
7. Two site specific deletions and t (1:14) translocation restricted to human T cell acute leukemia disrupt the 5′ part of TAL-1 gene
8. The TAL gene undergoes chromosome translocation in T cell leukemia and potentially encodes a Helix-Loop-Helix protein
9. Antiapoptotic effect of ectopic TAL-1/SCL expression in a human leukemic T cell line
10. T cell antigen receptor generation and T cell recognition
11. Extensive junctional diversity of rearranged human TCR δ genes
12. Southern blotting patterns, frequencies and junctional diversity of T cell receptor δ gene rearrangements in acute lymphoblastic leukemia
13. Extensive junctional diversity of TCR δ expression in T-acute lymphoblastic leukemia. Implication for detection of minimal residual disease
14. Prognostic value of minimal residual disease in acute lymphoblastic leukemia in childhood
15. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia
16. Analysis of Ig and T cell receptor genes in 40 childhood acute lymphoblastic leukemias at diagnosis and subsequent relapse: Implications for the detection of minimal residual disease by polymerase chain reaction analysis
17. Detection of minimal residual disease in acute leukemias: Methodologic advances and clinical significance
18. Detection of minimal residual disease in acute leukemia patients
19. Immunoglobulin and T cell receptor gene rearrangement patterns in acute lymphoblastic leukemia are less mature in adults than in children: Implications for selection of PCR targets for detection of minimal residual disease
20. Cross-lineage T cell receptor gene rearrangement occur in more than 90% of childhood precursor B acute lymphoblastic leukemias: Alternate PCR targets for detection of minimal residual disease
21. Real time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional regions specific TaqMan probes
22. Primers and protocols for standardized MRD detection in ALL using immunoglobulin and T cell receptor gene rearrangements and TAL-1 deletions as PCR targets. Report of the BIOMED-1 concerted action investigation of minimal residual disease in acute leukemias
23. Prognostic variables and survival in pediatric acute lymphoblastic leukemia
24. T cell receptor γ and δ gene rearrangements in T cell acute lymphoblastic leukemia in Indian patients
25. Phenotypic characteristics of T cell acute lymphoblastic leukemia in India
26. Characterization of immunoglobulin and T cell receptor gene rearrangement patterns in childhood acute lymphoblastic leukemia in India
27. TAL-1 deletion in T cell acute lymphoblastic leukemia: Implications in the detection of minimal residual disease
28. Molecular characterization of SCL rearrangements in T cell ALL from India and Egypt
29. Rearrangement of the TAL-1 locus as clonal markers for T cell ALL
30. Clinical significance of TAL-1 gene alteration in childhood T-ALL and lymphoma
31. Site-specific deletions involving the TAL-1 and SIL genes are restricted to cells of T cell receptor α/β lineage: T cell receptor δ gene deletion mechanism affects multiple genes
32. Assessment of clonal evolution at Ig/TCR loci in acute lymphoblastic leukemia by single strand conformation polymorphism studies and highly resolutive PCR derived methods: Implication for a general strategy of minimal residual disease detection
33. Detection of T cell receptor delta gene rearrangements in T cell malignancies by clonal-specific PCR and its application to detect minimal residual disease
34. Immunophenotype and clinical features of T cell receptor gammadelta + T lineage acute lymphoblastic leukemia
35. Study of the CD3-associated T cell receptors reveals further differences between T cell acute lymphoblastic lymphoma and leukemia
36. T cell receptor γδ/CD3+ 4-8 T cell acute lymphoblastic leukemias: A distinct subgroup of leukemias in children. A report of five cases
37. Immunophenotypic and immunogenotypic characteristics of TCR γ/δ+ T cell acute lymphoblastic leukemia
38. T cell receptor gamma (TCRG) gene rearrangement in T cell acute lymphoblastic leukemia reflect 'end stage' recombinations: Implications for minimal residual disease monitoring
39. Detection of minimal residual disease in acute lymphoblastic leukemia by in vitro amplification of rearranged TCR δ chain sequences
40. Detection of minimal residual disease in T-acute lymphoblastic leukemia using PCR predicts impending relapse
41. Long-term follow-up of minimal residual disease in childhood acute lymphoblastic leukemia patients by PCR analysis of multiple clone-specific or malignancy-specific gene markers
42. Minimal residual disease in childhood acute lymphoblastic leukemia: Analysis of patients in complete clinical remission or with consecutive relapse
43. Detectable molecular residual disease at the beginning of maintenance therapy indicates poor outcome in children with T-acute lymphoblastic leukemia
44. Heteroduplex analysis of T cell receptor γ gene rearrangements for diagnosis and monitoring of cutaneous T cell lymphomas
45. Heteroduplex PCR analysis of rearranged T cell receptor genes for clonality assessment in suspect T cell proliferations
46. Detection of clonality by heteroduplex analysis of amplified junctional region of T cell receptor gamma in patients with T cell acute lymphoblastic leukemias